Systemic administration also worked, but local delivery produced the strongest results consistently
Additionally, AOD-9604 does not stimulate IGF-1 production or activate growth hormone receptors, pathways that would otherwise affect appetite-regulating neuropeptides
Therefore, consistent sourcing and documented handling procedures remain important throughout the research process
Multiple clinical trials and controlled studies have demonstrated: Statistically significant improvements in skin firmness and elasticity with consistent use Reduction in fine lines and wrinkle depth over 3-6 months of application Improved skin density, moisture retention, and surface texture Reduction in photodamage and hyperpigmentation Tightening of loose skin documented in both topical and injectable applications Citation: Leyden JJ et al
NuGlow is built around skin-quality and repair-focused compounds, bringing together peptide ingredients often discussed in relation to collagen, tissue renewal, and healthy-looking skin